Skip to content

Clinical trials

Completed trials in Argentina with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Status: Completed Country / region: Argentina Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20064
20073
20084
20092
20106
20118
20127
20135
20143
20155
201613
201711
201816
201910
20206
202111
202219
20237
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed153

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Italiano de Buenos Aires19
University of Gran Rosario11
National Council of Scientific and Technical Research, Argentina6
Hospital General de Niños Pedro de Elizalde5
Institute for Clinical Effectiveness and Health Policy5
Hospital Privado de Comunidad de Mar del Plata4
GlaxoSmithKline3
NICHD Global Network for Women's and Children's Health3
Pfizer3
Universidad Nacional de Córdoba3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases6
Heart Failure5
Hypertension5
Pulmonary Disease, Chronic Obstructive5
Coronary Artery Disease4
Pulmonary Atelectasis4
Breast Neoplasms3
COVID-193
Critical Illness3
Alzheimer Disease2

Trials

Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.